Publications
Detailed Information
Phosphorylation of ERK1/2 and prognosis of clear cell renal cell carcinoma
Cited 12 time in
Web of Science
Cited 14 time in Scopus
- Authors
- Issue Date
- 2008-10-14
- Publisher
- Elsevier
- Citation
- Urology. 2009;73(2):394-399
- Keywords
- Carcinoma, Renal Cell/*metabolism/mortality ; Female ; Humans ; Kidney Neoplasms/*metabolism/mortality ; Male ; Middle Aged ; Mitogen-Activated Protein Kinase 3/biosynthesis/*metabolism ; Phosphorylation ; Prognosis ; Survival Analysis
- Abstract
- OBJECTIVES: To evaluate the phosphorylation of extracellular signal-regulated kinases 1/2 (ERK1/2) in clear cell renal cell carcinoma (CCRCC) and to investigate its prognostic significance. ERK1/2 activation had been reported in RCC, but little is known about its prognostic significance. METHODS: We immunohistochemically analyzed phosphorylated ERK1/2 (pERK) expression using tissue microarrays in 328 CCRCC specimens. The percentage of tumor cells showing positive staining was evaluated and classified into 4 categories: 0, 0%; 1+, 1%-10%; 2+, 11%-50%; and 3+, > 50%. For statistical analysis, the cases were subdivided into pERK-low (0 and 1+) and pERK-high (2+ and 3+) expression. RESULTS: Our study showed significantly greater expression of pERK in CCRCC than in non-neoplastic renal parenchyma. pERK-high expression was significantly associated with a low pT category (P = .046). The survival analysis showed a significant association between pERK-high expression and better progression-free survival (P = .014). Furthermore, the prognostic significance of pERK expression was quite different between small CCRCC (size < or = 7 cm) and large CCRCC (size > 7 cm) lesions. In small CCRCC, pERK-high expression correlated significantly with better cancer-specific survival (P = .018) and better progression-free survival (P < .001). However, no correlation was found between pERK expression and survival in large CCRCC. CONCLUSIONS: High expression of pERK in CCRCC was associated with a low pT category and showed a longer progression-free survival, especially in small CCRCC. Although the biologic mechanism of the ERK pathway in CCRCC remains unknown, the results of this study suggest that pERK expression is a positive prognosticator for survival in those with small CCRCC.
- ISSN
- 1527-9995 (Electronic)
- Language
- English
- URI
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18849062
http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6VJW-4TN5MCV-1-5&_cdi=6105&_user=168665&_orig=search&_coverDate=02%2F28%2F2009&_sk=999269997&view=c&wchp=dGLzVtb-zSkWz&md5=445ad4456c1cf1c73ffb9bc8b176b197&ie=/sdarticle.pdf
https://hdl.handle.net/10371/68373
- Files in This Item:
- There are no files associated with this item.
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.